StockDuty ← Dashboard Nov 06, 2026 11:00 AM ET
SignalCorporate

MannKind anticipates $1B in revenue from United Therapeutics deal from 2027-2030 as it targets Q4 profitability

MannKind projects $1B revenue from United Therapeutics deal 2027–2030, targeting Q4 profitability.

MannKind projects $1B revenue from United Therapeutics deal 2027–2030, targeting Q4 profitability.
MannKind projects $1B revenue from United Therapeutics deal 2027–2030, targeting Q4 profitability. — impact context not separately stored; see What changed.
Sources